AU Stock MarketDetailed Quotes

Neuroscientific Biopharmaceuticals Ltd (NSB)

Watchlist

0.099
-0.001-1.00%

20min DelayMarket Closed May 15 16:00 AET

32.92MMarket Cap-7.62P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neuroscientific Biopharmaceuticals Ltd (NSB) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2025

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

Total revenue

Cost of revenue

Gross profit

Operating expense

-2.31%2.01M

-66.42%2.06M

-41.69%6.12M

148.69%10.5M

43.59%4.22M

65.41%2.94M

1.78M

Selling and administrative expenses

28.67%1.65M

-27.15%1.29M

-35.40%1.77M

73.58%2.73M

36.66%1.57M

96.96%1.15M

--584.95K

-General and administrative expense

28.67%1.65M

-27.15%1.29M

-35.40%1.77M

73.58%2.73M

36.66%1.57M

96.96%1.15M

--584.95K

Research and development costs

-73.86%128.73K

-87.77%492.46K

-44.24%4.03M

225.53%7.22M

55.89%2.22M

94.78%1.42M

--730.42K

Depreciation amortization depletion

1.58%92.78K

57.87%91.34K

-10.88%57.85K

5.71%64.92K

8.38%61.41K

2.64%56.66K

--55.21K

-Depreciation and amortization

1.58%92.78K

57.87%91.34K

-10.88%57.85K

5.71%64.92K

8.38%61.41K

2.64%56.66K

--55.21K

Other operating expenses

-28.90%132.63K

-32.14%186.54K

-43.41%274.87K

31.35%485.73K

19.32%369.79K

-23.97%309.91K

--407.63K

Operating profit

2.31%-2.01M

66.42%-2.06M

41.69%-6.12M

-148.69%-10.5M

-43.59%-4.22M

-65.41%-2.94M

-1.78M

Net non-operating interest income (expenses)

-3.15%163.62K

64.35%168.94K

50.18%102.8K

148.17%68.45K

-14.65%27.58K

-62.18%32.32K

85.44K

Non-operating interest income

-7.19%166.08K

66.41%178.94K

57.09%107.53K

147.60%68.45K

-22.63%27.65K

-58.18%35.73K

--85.44K

Non-operating interest expense

-75.36%2.46K

111.17%10K

--4.73K

----

-98.16%63

--3.42K

----

Other net income (expenses)

-55.34%2.21M

4.95M

2,411.67%1.02M

19.77%40.54K

33.85K

Other non-operating income (expenses)

----

-55.34%2.21M

--4.95M

----

2,411.67%1.02M

19.77%40.54K

--33.85K

Income before tax

-669.23%-1.85M

130.34%324.21K

89.76%-1.07M

-228.38%-10.44M

-10.78%-3.18M

-72.92%-2.87M

-1.66M

Income tax

Earnings from equity interest net of tax

Net income

-669.23%-1.85M

130.34%324.21K

89.76%-1.07M

-228.38%-10.44M

-10.78%-3.18M

-72.92%-2.87M

-1.66M

Net income continuous operations

-669.23%-1.85M

130.34%324.21K

89.76%-1.07M

-228.38%-10.44M

-10.78%-3.18M

-72.92%-2.87M

---1.66M

Noncontrolling interests

Net income attributable to the company

-669.23%-1.85M

130.34%324.21K

89.76%-1.07M

-228.38%-10.44M

-10.78%-3.18M

-72.92%-2.87M

-1.66M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-669.23%-1.85M

130.34%324.21K

89.76%-1.07M

-228.38%-10.44M

-10.78%-3.18M

-72.92%-2.87M

-1.66M

Diluted earnings per share

-672.73%-0.0126

129.73%0.0022

89.82%-0.0074

-227.48%-0.0727

39.51%-0.0222

-58.19%-0.0367

-0.0232

Basic earnings per share

-672.73%-0.0126

129.73%0.0022

89.82%-0.0074

-227.48%-0.0727

39.51%-0.0222

-58.19%-0.0367

-0.0232

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2025	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019
Total revenue
Cost of revenue
Gross profit
Operating expense	-2.31%2.01M	-66.42%2.06M	-41.69%6.12M	148.69%10.5M	43.59%4.22M	65.41%2.94M	1.78M
Selling and administrative expenses	28.67%1.65M	-27.15%1.29M	-35.40%1.77M	73.58%2.73M	36.66%1.57M	96.96%1.15M	--584.95K
-General and administrative expense	28.67%1.65M	-27.15%1.29M	-35.40%1.77M	73.58%2.73M	36.66%1.57M	96.96%1.15M	--584.95K
Research and development costs	-73.86%128.73K	-87.77%492.46K	-44.24%4.03M	225.53%7.22M	55.89%2.22M	94.78%1.42M	--730.42K
Depreciation amortization depletion	1.58%92.78K	57.87%91.34K	-10.88%57.85K	5.71%64.92K	8.38%61.41K	2.64%56.66K	--55.21K
-Depreciation and amortization	1.58%92.78K	57.87%91.34K	-10.88%57.85K	5.71%64.92K	8.38%61.41K	2.64%56.66K	--55.21K
Other operating expenses	-28.90%132.63K	-32.14%186.54K	-43.41%274.87K	31.35%485.73K	19.32%369.79K	-23.97%309.91K	--407.63K
Operating profit	2.31%-2.01M	66.42%-2.06M	41.69%-6.12M	-148.69%-10.5M	-43.59%-4.22M	-65.41%-2.94M	-1.78M
Net non-operating interest income (expenses)	-3.15%163.62K	64.35%168.94K	50.18%102.8K	148.17%68.45K	-14.65%27.58K	-62.18%32.32K	85.44K
Non-operating interest income	-7.19%166.08K	66.41%178.94K	57.09%107.53K	147.60%68.45K	-22.63%27.65K	-58.18%35.73K	--85.44K
Non-operating interest expense	-75.36%2.46K	111.17%10K	--4.73K	----	-98.16%63	--3.42K	----
Other net income (expenses)		-55.34%2.21M	4.95M		2,411.67%1.02M	19.77%40.54K	33.85K
Other non-operating income (expenses)	----	-55.34%2.21M	--4.95M	----	2,411.67%1.02M	19.77%40.54K	--33.85K
Income before tax	-669.23%-1.85M	130.34%324.21K	89.76%-1.07M	-228.38%-10.44M	-10.78%-3.18M	-72.92%-2.87M	-1.66M
Income tax	0	0	0	0	0	0	0
Earnings from equity interest net of tax
Net income	-669.23%-1.85M	130.34%324.21K	89.76%-1.07M	-228.38%-10.44M	-10.78%-3.18M	-72.92%-2.87M	-1.66M
Net income continuous operations	-669.23%-1.85M	130.34%324.21K	89.76%-1.07M	-228.38%-10.44M	-10.78%-3.18M	-72.92%-2.87M	---1.66M
Noncontrolling interests
Net income attributable to the company	-669.23%-1.85M	130.34%324.21K	89.76%-1.07M	-228.38%-10.44M	-10.78%-3.18M	-72.92%-2.87M	-1.66M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-669.23%-1.85M	130.34%324.21K	89.76%-1.07M	-228.38%-10.44M	-10.78%-3.18M	-72.92%-2.87M	-1.66M
Diluted earnings per share	-672.73%-0.0126	129.73%0.0022	89.82%-0.0074	-227.48%-0.0727	39.51%-0.0222	-58.19%-0.0367	-0.0232
Basic earnings per share	-672.73%-0.0126	129.73%0.0022	89.82%-0.0074	-227.48%-0.0727	39.51%-0.0222	-58.19%-0.0367	-0.0232
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm